A. Papalexandri

发表

Favorable impact of extracorporeal photopheresis in acute and chronic graft versus host disease: Prospective single‐center study

E. Yannaki, A. Anagnostopoulos, I. Sakellari, 2018, Journal of clinical apheresis.

Extracorporeal photopheresis in refractory chronic graft-versus-host disease: the influence on peripheral blood T cell subpopulations. A study by the Hellenic Association of Hematology.

S. Papageorgiou, V. Pappa, A. Anagnostopoulos, 2012, Transfusion and apheresis science : official journal of the World Apheresis Association : official journal of the European Society for Haemapheresis.

Extracorporeal photopheresis in the treatment of chronic graft-versus-host disease. The Hellenic experience: a study by the Hellenic association of hematology.

S. Papageorgiou, A. Anagnostopoulos, I. Sakellari, 2012, Transfusion and apheresis science : official journal of the World Apheresis Association : official journal of the European Society for Haemapheresis.

Real-world data of thrombotic microangiopathy management: The key role of ADAMTS13 activity and complement testing

M. Papathanasiou, G. Karavalakis, A. Anagnostopoulos, 2021 .

Genetic and Functional Evidence of Complement Dysregulation in Multiple Myeloma Patients with Carfilzomib-Induced Thrombotic Microangiopathy Compared to Controls

M. Dimopoulos, E. Kastritis, M. Gavriatopoulou, 2022, Journal of clinical medicine.

Targeted Genotyping of MIS-C Patients Reveals a Potential Alternative Pathway Mediated Complement Dysregulation during COVID-19 Infection

D. Zafeiriou, E. Roilides, A. Tragiannidis, 2022, Current issues in molecular biology.

Predictors of Transplant-Associated Thrombotic Microangiopathy in Patients With Overlap or Chronic Graft-vs-Host-Disease.

T. Chatzikonstantinou, E. Yannaki, A. Anagnostopoulos, 2021, Transplantation proceedings.

Endothelial and Complement Activation As Predictors of Survival in Adult Allogeneic Hematopoietic Cell Transplantation

T. Chatzikonstantinou, E. Yannaki, A. Anagnostopoulos, 2020, HemaSphere.

Intestinal thrombotic microangiopathy: a distinct entity in the spectrum of graft-versus-host disease

A. Anagnostopoulos, A. Ilias, I. Sakellari, 2019, International Journal of Hematology.

Adolescents and young adults (AYA) with acute myeloid leukemia (AML): real-world long-term results and age-specific outcomes

M. Papathanasiou, A. Athanasiadou, C. Demosthenous, 2022, Leukemia & lymphoma.

Secondary Acute Myeloid Leukemia (sAML): Similarly Dismal Outcomes of AML After an Antecedent Hematologic Disorder and Therapy Related AML.

M. Papathanasiou, A. Anagnostopoulos, A. Athanasiadou, 2021, Clinical lymphoma, myeloma & leukemia.

Linking Complement Activation, Coagulation, and Neutrophils in Transplant-Associated Thrombotic Microangiopathy

R. Brodsky, A. Anagnostopoulos, I. Mitroulis, 2019, Thrombosis and Haemostasis.

Patient risk stratification and tailored clinical management of post‐transplant CMV‐, EBV‐, and BKV‐infections by monitoring virus‐specific T‐cell immunity

V. Papadopoulos, E. Yannaki, A. Anagnostopoulos, 2021, EJHaem.

Genetic prediction of ICU hospitalization and mortality in COVID‐19 patients using artificial neural networks

P. G. Asteris, A. Gandomi, P. Samui, 2022, Journal of cellular and molecular medicine.

Targeted genotyping of COVID-19 patients reveals a signature of complement C3 and factor B coding SNPs associated with severe infection

A. Anagnostopoulos, I. Sakellari, E. Gavriilaki, 2023, Immunobiology.

Skewing of the T-cell receptor repertoire in patients receiving rituximab after allogeneic hematopoietic cell transplantation: what lies beneath?

K. Stamatopoulos, D. Margaritis, I. Kotsianidis, 2019, Leukemia & lymphoma.

Cytotoxic T cell-mediated gastritis after rituximab treatment for gastric malt lymphoma

K. Stamatopoulos, A. Anagnostopoulos, E. Stalika, 2014, Leukemia & lymphoma.

Familial CD3+ T large granular lymphocyte leukemia: evidence that genetic predisposition and antigen selection promote clonal cytotoxic T-cell responses

K. Stamatopoulos, H. Papadaki, A. Anagnostopoulos, 2014, Leukemia & lymphoma.

Transient monoclonal CD3+ T large granular lymphocyte proliferation in a case of mantle cell lymphoma with Rituximab‐associated late onset neutropenia

K. Stamatopoulos, A. Anagnostopoulos, E. Stalika, 2011, Hematological oncology.

Molecular evidence for repertoire skewing of T large granular lymphocyte proliferation after allogeneic hematopoietic SCT: report of two cases

K. Stamatopoulos, A. Anagnostopoulos, M. Karypidou, 2013, Bone Marrow Transplantation.

Pretransplant Genetic Susceptibility: Clinical Relevance in Transplant-Associated Thrombotic Microangiopathy

K. Stamatopoulos, R. Brodsky, M. Tsagiopoulou, 2020, Thrombosis and Haemostasis.

Pre- and Post-transfusion Complement Activation in Transfusion-dependent β-thalassaemia

A. Anagnostopoulos, E. Gavriilaki, A. Papalexandri, 2018, HemaSphere.

Genetic justification of severe COVID-19 using a rigorous algorithm

P. G. Asteris, Mohammadreza Koopialipoor, D. J. Armaghani, 2021, Clinical Immunology.

Survival advantage of treosulfan plus fludarabine before allogeneic hematopoietic cell transplantation for older or comorbid patients with myeloid malignancies.

M. Papathanasiou, K. Antoniadis, A. Anagnostopoulos, 2021, Transplantation and cellular therapy.

Survival Advantage and Comparable Toxicity in Reduced-Toxicity Treosulfan-Based versus Reduced-Intensity Busulfan-Based Conditioning Regimen in Myelodysplastic Syndrome and Acute Myeloid Leukemia Patients after Allogeneic Hematopoietic Cell Transplantation.

E. Yannaki, A. Anagnostopoulos, A. Athanasiadou, 2017, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

In vitro evidence of complement activation in patients with sickle cell disease

M. Mainou, A. Anagnostopoulos, A. Athanasiadou, 2017, Haematologica.

Differences in the immunoglobulin gene repertoires of IgG versus IgA multiple myeloma allude to distinct immunopathogenetic trajectories

K. Stamatopoulos, M. Ladetto, E. Hatjiharissi, 2023, Frontiers in Oncology.

Context-dependent T-cell Receptor Gene Repertoire Profiles in Proliferations of T Large Granular Lymphocytes

K. Stamatopoulos, A. Langerak, A. Agathangelidis, 2023, HemaSphere.

Neutralizing antibody and T cell responses to SARS-CoV-2 vaccination in hematopoietic cell transplant recipients

G. Karavalakis, M. Giannaki, E. Yannaki, 2022, Bone Marrow Transplantation.

Immune Response of Adult Sickle Cell Disease Patients after COVID-19 Vaccination: The Experience of a Greek Center

A. Anagnostopoulos, I. Sakellari, E. Gavriilaki, 2022, Journal of clinical medicine.

Blast Crisis of CML After TKI Discontinuation in a Patient With Previous Stable Deep Molecular Response: Is It Safe to Stop?

M. Papathanasiou, A. Anagnostopoulos, A. Athanasiadou, 2018, HemaSphere.

Pre-Emptive Use of Rituximab in Epstein–Barr Virus Reactivation: Incidence, Predictive Factors, Monitoring, and Outcomes

E. Yannaki, A. Anagnostopoulos, C. Demosthenous, 2023, International journal of molecular sciences.

SARS-CoV-2-specific T cell therapy for severe COVID-19: a randomized phase 1/2 trial

M. Giannaki, G. Karavalakis, A. Georgakopoulou, 2023, Nature Medicine.

Distinct Immunogenetic Signatures in IgA Versus IgG Multiple Myeloma

K. Stamatopoulos, S. Ferrero, M. Ladetto, 2016 .

Increased Complement Activation and Decreased ADAMTS13 Activity Are Associated with Genetic Susceptibility in Patients with Preeclampsia/HELLP Syndrome Compared to Healthy Pregnancies: An Observational Case-Controlled Study

A. Papalexandri, K. Psarras, E. Vlachaki, 2024, Journal of personalized medicine.

Soluble Urokinase-Type Plasminogen Activator Receptor (suPAR) and Growth Differentiation Factor-15 (GDF-15) Levels Are Significantly Associated with Endothelial Injury Indices in Adult Allogeneic Hematopoietic Cell Transplantation Recipients

E. Yannaki, I. Sakellari, I. Batsis, 2023, International journal of molecular sciences.